Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
GRF:BME
Grifols SA Class A
€9.04
+0.89%
(+0.080) 1D
4 મે, 03:14:51 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GRF...
ખોલો
€9.05
High
€9.10
Low
€8.88
Mkt. cap
૫.૭૧ અબજ
Avg. vol.
૨૬.૩૭ લાખ
Volume
૯.૨૮ લાખ
Dividend
૧.૬૬%
Quarterly dividend
€0.04
Ex dividend date
11 ઑગસ્ટ, 2025
P/E ratio
૧૫.૩૦
52-wk high
€13.70
52-wk low
€8.01
EPS
€0.59
Shares outstanding
૪૨.૬૧ કરોડ
No. of employees
૨૫ હજાર
News stories
From sources across the web
પ્રોફાઇલ
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A
CEONacho Abia
Employees25.3 હજાર
Founded18 નવે, 1940
Headquarters-
Sector-
Websitegrifols.com
Last report
26 ફેબ્રુ, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -EUR
Revenue / Estimate
૧.૯૮ અબજ/ (૧.૯૬ અબજ est.)EUR
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
ડિસે 2025
Revenue
1.79 અબજ
1.89 અબજ
1.87 અબજ
1.98 અબજ
Cost of goods sold
1.08 અબજ
1.15 અબજ
1.11 અબજ
1.28 અબજ
Cost of revenue
1.08 અબજ
1.15 અબજ
1.11 અબજ
1.28 અબજ
Research and development expenses
9.60 કરોડ
9.62 કરોડ
9.70 કરોડ
9.08 કરોડ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.54 કરોડ
29.81 કરોડ
27.38 કરોડ
26.29 કરોડ
Operating expense
41.14 કરોડ
39.43 કરોડ
37.03 કરોડ
35.31 કરોડ
Total operating expenses
1.49 અબજ
1.54 અબજ
1.48 અબજ
1.63 અબજ
Operating income
29.32 કરોડ
34.95 કરોડ
38.12 કરોડ
34.74 કરોડ
Other non operating income
-
80.81 લાખ
-
-3.30 કરોડ
EBT including unusual items
11.53 કરોડ
19.05 કરોડ
19.81 કરોડ
11.11 કરોડ
EBT excluding unusual items
13.45 કરોડ
19.05 કરોડ
22.72 કરોડ
18.31 કરોડ
Income tax expense
2.28 કરોડ
5.21 કરોડ
5.47 કરોડ
-1.47 કરોડ
Effective tax rate
19.82%
27.36%
27.61%
-13.21%
Other operating expenses
-
-
-4.30 લાખ
-5.70 લાખ
Net income
5.97 કરોડ
11.71 કરોડ
12.70 કરોડ
9.82 કરોડ
Net profit margin
3.34%
6.19%
6.81%
4.96%
Earnings per share
-
0.19
-
-
Interest and investment income
-
95.55 લાખ
-
3.60 કરોડ
Interest expense
-15.36 કરોડ
-14.14 કરોડ
-15.61 કરોડ
-10.80 કરોડ
Net interest expenses
-15.36 કરોડ
-13.19 કરોડ
-15.61 કરોડ
-7.20 કરોડ
Depreciation and amortization charges
-
-
-
-
EBITDA
40.50 કરોડ
41.42 કરોડ
48.40 કરોડ
42.29 કરોડ
Gain or loss from assets sale
-
7.32 લાખ
-
20.00 લાખ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer